These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7584093)

  • 41. In vivo expression of beta-galactosidase in hippocampal neurons by HSV-mediated gene transfer.
    Fink DJ; Sternberg LR; Weber PC; Mata M; Goins WF; Glorioso JC
    Hum Gene Ther; 1992 Feb; 3(1):11-9. PubMed ID: 1314100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid and stable gene expression in hippocampal slice cultures from a defective HSV-1 vector.
    Bahr BA; Neve RL; Sharp J; Geller AI; Lynch G
    Brain Res Mol Brain Res; 1994 Oct; 26(1-2):277-85. PubMed ID: 7531803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of exogenous nerve growth factor on neurotoxicity of and neuronal gene delivery by a herpes simplex amplicon vector in the rat brain.
    Pakzaban P; Geller AI; Isacson O
    Hum Gene Ther; 1994 Aug; 5(8):987-95. PubMed ID: 7948148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system.
    Ho DY; McLaughlin JR; Sapolsky RM
    Brain Res Mol Brain Res; 1996 Sep; 41(1-2):200-9. PubMed ID: 8883953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A limited innate immune response is induced by a replication-defective herpes simplex virus vector following delivery to the murine central nervous system.
    Zeier Z; Aguilar JS; Lopez CM; Devi-Rao GB; Watson ZL; Baker HV; Wagner EK; Bloom DC
    J Neurovirol; 2009 Sep; 15(5-6):411-24. PubMed ID: 20095947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Highly efficient and specific gene transfer to Purkinje cells in vivo using a herpes simplex virus I amplicon.
    Agudo M; Trejo JL; Lim F; Avila J; Torres-Alemán I; Diaz-Nido J; Wandosell F
    Hum Gene Ther; 2002 Mar; 13(5):665-74. PubMed ID: 11916489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Infection of cultured striatal neurons with a defective HSV-1 vector: implications for gene therapy.
    Freese A; Geller A
    Nucleic Acids Res; 1991 Dec; 19(25):7219-23. PubMed ID: 1662813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli beta-galactosidase.
    Geller AI; Freese A
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1149-53. PubMed ID: 2153970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel vestibular approach for gene transfer into the inner ear.
    Praetorius M; Knipper M; Schick B; Tan J; Limberger A; Carnicero E; Alonso MT; Schimmang T
    Audiol Neurootol; 2002; 7(6):324-34. PubMed ID: 12463195
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A perspective of gene therapy in the glaucomas.
    Kaufman PL; Jia WW; Tan J; Chen Z; Gabelt BT; Booth V; Tufaro F; Cynader M
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S91-7. PubMed ID: 10416752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons.
    Geller AI; Breakefield XO
    Science; 1988 Sep; 241(4873):1667-9. PubMed ID: 2843986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Replication-defective genomic herpes simplex vectors: design and production.
    Burton EA; Bai Q; Goins WF; Glorioso JC
    Curr Opin Biotechnol; 2002 Oct; 13(5):424-8. PubMed ID: 12459332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and biodistribution studies of an HSV multigene vector following intracranial delivery to non-human primates.
    Wolfe D; Niranjan A; Trichel A; Wiley C; Ozuer A; Kanal E; Kondziolka D; Krisky D; Goss J; Deluca N; Murphey-Corb M; Glorioso JC
    Gene Ther; 2004 Dec; 11(23):1675-84. PubMed ID: 15306839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transfer of FGF-2 via HSV-1-based amplicon vectors promotes efficient formation of neurons from embryonic stem cells.
    Vicario I; Schimmang T
    J Neurosci Methods; 2003 Feb; 123(1):55-60. PubMed ID: 12581849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene transfer to ovine corneal endothelium.
    Klebe S; Sykes PJ; Coster DJ; Bloom DC; Williams KA
    Clin Exp Ophthalmol; 2001 Oct; 29(5):316-22. PubMed ID: 11720159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene transfer into the mammalian inner ear using HSV-1 and vaccinia virus vectors.
    Derby ML; Sena-Esteves M; Breakefield XO; Corey DP
    Hear Res; 1999 Aug; 134(1-2):1-8. PubMed ID: 10452370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modified herpes simplex virus delivery of enhanced GFP into the central nervous system.
    Sandler VM; Wang S; Angelo K; Lo HG; Breakefield XO; Clapham DE
    J Neurosci Methods; 2002 Dec; 121(2):211-9. PubMed ID: 12468010
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Herpes simplex viral vectors for therapeutic gene delivery to ocular tissues. Recent breakthroughs in the molecular genetics of ocular diseases.
    Pepose JS; Leib DA
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2662-6. PubMed ID: 8188460
    [No Abstract]   [Full Text] [Related]  

  • 59. A new approach with less damage: intranasal delivery of tetracycline-inducible replication-defective herpes simplex virus type-1 vector to brain.
    Jiang Y; Wei N; Zhu J; Zhai D; Wu L; Chen M; Xu G; Liu X
    Neuroscience; 2012 Jan; 201():96-104. PubMed ID: 22101000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Localized gene transfer into organotypic hippocampal slice cultures and acute hippocampal slices.
    Casaccia-Bonnefil P; Benedikz E; Shen H; Stelzer A; Edelstein D; Geschwind M; Brownlee M; Federoff HJ; Bergold PJ
    J Neurosci Methods; 1993 Dec; 50(3):341-51. PubMed ID: 8152244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.